These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12654968)

  • 81.
    Mthiyane T; Millard J; Adamson J; Balakrishna Y; Connolly C; Owen A; Rustomjee R; Dheda K; McIlleron H; Pym AS
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964788
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Association of polymorphism in cytochrome P450 2D6 and N-acetyltransferase-2 with Parkinson's disease.
    Singh M; Khanna VK; Shukla R; Parmar D
    Dis Markers; 2010; 28(2):87-93. PubMed ID: 20364044
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Relationship between polymorphism of N-acetyltransferase 2 and genetic susceptibility to laryngeal carcinoma].
    Lei D; Pan X; Guo C; Xu F; Zhang L; Liu D; Luan X
    Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):154-6. PubMed ID: 12015038
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The N-acetyltransferase (NAT) gene: an early risk marker for diabetic nephropathy in Japanese type 2 diabetic patients?
    Neugebauer S; Baba T; Watanabe T; Ishizaki T; Kurokawa K
    Diabet Med; 1994 Oct; 11(8):783-8. PubMed ID: 7851073
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Novel human N-acetyltransferase 2 alleles that differ in mechanism for slow acetylator phenotype.
    Leff MA; Fretland AJ; Doll MA; Hein DW
    J Biol Chem; 1999 Dec; 274(49):34519-22. PubMed ID: 10574910
    [TBL] [Abstract][Full Text] [Related]  

  • 86. N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group.
    Ng CS; Hasnat A; Al Maruf A; Ahmed MU; Pirmohamed M; Day CP; Aithal GP; Daly AK
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1079-86. PubMed ID: 24888881
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Correlation between N-acetyltransferase activity and NAT2 genotype in Chinese males.
    Rothman N; Hayes RB; Bi W; Caporaso N; Broly F; Woosley RL; Yin S; Feng P; You X; Meyer UA
    Pharmacogenetics; 1993 Oct; 3(5):250-5. PubMed ID: 8287063
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer.
    Risch A; Wallace DM; Bathers S; Sim E
    Hum Mol Genet; 1995 Feb; 4(2):231-6. PubMed ID: 7757072
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Acetylation polymorphism and prevalence of colorectal adenomas.
    Probst-Hensch NM; Haile RW; Ingles SA; Longnecker MP; Han CY; Lin BK; Lee DB; Sakamoto GT; Frankl HD; Lee ER
    Cancer Res; 1995 May; 55(10):2017-20. PubMed ID: 7743494
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations.
    Deloménie C; Sica L; Grant DM; Krishnamoorthy R; Dupret JM
    Pharmacogenetics; 1996 Apr; 6(2):177-85. PubMed ID: 9156695
    [TBL] [Abstract][Full Text] [Related]  

  • 91. N-Acetyltransferase-2 (NAT2) genotype frequency among Jordanian volunteers.
    Jarrar YB; Ismail S; Irshaid YM
    Int J Clin Pharmacol Ther; 2010 Oct; 48(10):688-94. PubMed ID: 20875375
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Genetic analysis of the NAT2 and CYP2D6 polymorphisms in white patients with non-insulin-dependent diabetes mellitus.
    Agúndez JA; Menaya JG; Tejeda R; Lago F; Chávez M; Benítez J
    Pharmacogenetics; 1996 Oct; 6(5):465-72. PubMed ID: 8946479
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Slow acetylator genotype of N-acetyl transferase2 (NAT2) is associated with increased susceptibility to gallbladder cancer: the cancer risk not modulated by gallstone disease.
    Pandey SN; Modi DR; Choudhuri G; Mittall B
    Cancer Biol Ther; 2007 Jan; 6(1):91-6. PubMed ID: 17224641
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Impact of N-acetyltransferase polymorphism (NAT2) in hepatocellular carcinoma (HCC)--an investigation in a department of surgical medicine.
    Farker K; Schotte U; Scheele J; Hoffmann A
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):387-91. PubMed ID: 12877350
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Variation of the N-acetyltransferase 2 gene in a Romanian and a Kyrgyz population.
    Rabstein S; Unfried K; Ranft U; Illig T; Kolz M; Rihs HP; Mambetova C; Vlad M; Brüning T; Pesch B
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):138-41. PubMed ID: 16434599
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype-genotype correlation with the sulfamethazine test.
    Taja-Chayeb L; González-Fierro A; Miguez-Muñoz C; Trejo-Becerril C; Cruz-Hernandez Ede L; Cantu D; Agundez JA; Vidal-Millan S; Gutierrez O; Dueñas-González A
    Pharmacogenet Genomics; 2011 Dec; 21(12):894-901. PubMed ID: 21946899
    [TBL] [Abstract][Full Text] [Related]  

  • 97. NAT2 slow acetylator function as a risk indicator for age-related cataract formation.
    Meyer D; Parkin DP; Seifart HI; Maritz JS; Engelbrecht AH; Werely CJ; van Helden PD
    Pharmacogenetics; 2003 May; 13(5):285-9. PubMed ID: 12724621
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Glutathione S-transferase (GST) M1, T1 and N-acetyltransferase 2 (NAT2) polymorphisms and urothelial cancer risk with tobacco smoking.
    Tsukino H; Nakao H; Kuroda Y; Imai H; Inatomi H; Osada Y; Katoh T
    Eur J Cancer Prev; 2004 Dec; 13(6):509-14. PubMed ID: 15548945
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Association of CYP2E1 and NAT2 polymorphisms with lung cancer susceptibility among Mongolian and Han populations in the Inner Mongolian region.
    Zhang JW; Yu WJ; Sheng XM; Chang FH; Bai TY; Lv XL; Wang G; Liu SZ
    Asian Pac J Cancer Prev; 2014; 15(21):9203-10. PubMed ID: 25422202
    [TBL] [Abstract][Full Text] [Related]  

  • 100. N-acetyltransferase 2 polymorphism is associated with bladder cancer risk: An updated meta-analysis based on 54 case-control studies.
    Song Y; Qi X; Liu X
    Gene; 2020 Oct; 757():144924. PubMed ID: 32622992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.